U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.

Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s ...

MISSOULA, Mont. — NBC MT Today: Impact of grant, loan pause; Purdue Pharma settlement; record year at MSO ...

Purdue was instrumental in creating the US opioid crisis via aggressive marketing that did not reflect the true addiction ...

The money could benefit the 14 syringe service programs across the five boroughs that offer harm reduction services.

This month’s KELOLAND Living Book Club selection examines the history of the Sackler family, including the founding of Purdue Pharma, its role in the marketing of pharmaceuticals, and the ...

Montana will sign onto a proposed national settlement with Purdue Pharma and its owners, the Sackler family, for their role in sparking the opioid crisis.

Last week, members of the Sackler family, which owns the pharmaceutical company known for selling OxyContin, agreed to a $7.4 ...

Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over the toll of OxyContin - On Thursday, Purdue Pharma ...